Lilly broadens Ambrx alliance
Eli Lilly and Co. expanded its alliance with San Diego-based Ambrx Inc., the companies announced today. Indianapolis-based Lilly will use Ambrx’s protein-optimization technology, called ReCODE, in its efforts to develop biotech drugs. The two companies will try to bring to market drugs for treating metabolic diseases, central nervous system disorders and other conditions. Lilly will […]